» Articles » PMID: 30696040

5p and 3p Strands of MiR-34 Family Members Have Differential Effects in Cell Proliferation, Migration, and Invasion in Cervical Cancer Cells

Abstract

The micro RNA (miR)-34 family is composed of 5p and 3p strands of miR-34a, miR-34b, and miR-34c. The 5p strand's expression and function is studied in cervical cancer. The 3p strand's function and regulation remain to be elucidated. To study the function of the passenger strands of miR-34 family members, we overexpressed 5p and 3p strands using a synthetic miRNA in cervical cell lines. Cell proliferation was evaluated using crystal violet. Migration and invasion were tested using transwell assays, Western blot, and zymography. Possible specific targets and cell signaling were investigated for each strand. We found that miR-34a-5p inhibited proliferation, migration, and cell invasion accompanied by matrix metalloproteinase 9 (MMP9) activity and microtubule-associated protein 2 (MAP2) protein reduction. We also found that miR-34b-5p and miR-34c-5p inhibit proliferation and migration, but not invasion. In contrast, miR-34c-5p inhibits MMP9 activity and MAP2 protein, while miR-34b-5p has no effect on these genes. Furthermore, miR-34a-3p and miR-34b-3p inhibit proliferation and migration, but not invasion, despite the later reducing MMP2 activity, while miR-34c-3p inhibit proliferation, migration, and cell invasion accompanied by MMP9 activity and MAP2 protein inhibition. The difference in cellular processes, MMP2 and MMP9 activity, and MAP2 protein inhibition by miR-34 family members suggests the participation of other regulated genes. This study provides insights into the roles of passenger strands (strand*) of the miR-34 family in cervical cancer.

Citing Articles

Profiling of miRNAs Contained in Circulating Extracellular Vesicles and Associated with Sepsis Development in Burn Patients: A Proof-of-Concept Study.

Schiavello M, Bosco O, Vizio B, Sciarrillo A, Pensa A, Pivetta E Int J Mol Sci. 2025; 26(5).

PMID: 40076471 PMC: 11899136. DOI: 10.3390/ijms26051844.


Regulates Muscle Growth and Development by Targeting .

Wu Y, Liu X, Fan Y, Zuo H, Niu X, Zuo B Cells. 2025; 14(5).

PMID: 40072107 PMC: 11898696. DOI: 10.3390/cells14050379.


miRNA-34a-5p inhibits chicken myoblasts proliferation and differentiation via NOTCH1 inhibition.

Ling X, Wang Q, Zhang J, Zhang H, Zhang L, Zhuo C Poult Sci. 2025; 104(3):104895.

PMID: 39970517 PMC: 11880695. DOI: 10.1016/j.psj.2025.104895.


MiR-34b promotes oxidative stress and induces cellular senescence through TWIST1 in human cervical cancer.

Sindhu K, Nalini V, Suraishkumar G, Karunagaran D Transl Oncol. 2024; 48:102063.

PMID: 39094513 PMC: 11342277. DOI: 10.1016/j.tranon.2024.102063.


Plant bioactive compounds driven microRNAs (miRNAs): A potential source and novel strategy targeting gene and cancer therapeutics.

Sumaira S, Vijayarathna S, Hemagirri M, Adnan M, Hassan M, Patel M Noncoding RNA Res. 2024; 9(4):1140-1158.

PMID: 39022680 PMC: 11250886. DOI: 10.1016/j.ncrna.2024.06.003.


References
1.
Guan S, Lu J, Zhao Y, Woodfield S, Zhang H, Xu X . TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis. Oncotarget. 2017; 8(20):33666-33675. PMC: 5464900. DOI: 10.18632/oncotarget.16895. View

2.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

3.
Refaat T, Donnelly E, Sachdev S, Parimi V, El Achy S, Dalal P . c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target. Am J Clin Oncol. 2015; 40(6):590-597. PMC: 4704991. DOI: 10.1097/COC.0000000000000203. View

4.
Wang W, Danaher R, Miller C, Berger J, Nubia V, Wilfred B . Expression of miR-15/107 family microRNAs in human tissues and cultured rat brain cells. Genomics Proteomics Bioinformatics. 2014; 12(1):19-30. PMC: 3975925. DOI: 10.1016/j.gpb.2013.10.003. View

5.
Cai K, Bao X, Kong X, Jinag W, Mao M, Chu J . Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. Int J Mol Med. 2010; 25(4):565-71. DOI: 10.3892/ijmm_00000378. View